Nucynta Tablet, Film Coated, Extended Release
Product Images NDC 24510-232
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Nucynta (NDC 24510-232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Collegium Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Nucynta 02)
This is a graph depicting the percent improvement of pain from baseline at week 15 of the treatment period for patients using either a placebo or the medication Nucynta ER. The x-axis shows percentage increments from 0 to 100, and the y-axis shows the number of patients with different degrees of pain improvement. The data labels indicate improvement percentages of 10, 20, 30, 40, 50, 60, 70, 80, 90, and 100.*
Figure 2 (Nucynta 03)
Figure 3 (Nucynta 04)
This is a chart showing the percent of patients who improved their pain from baseline after taking either placebo or NUCYNTA® ER. The chart shows different percentage ranges and the number of patients who fell within each range after 12 weeks. The chart suggests that NUCYNTA® ER was more effective than placebo in improving pain.*
Principal Display Panel (50 mg Tablet Bottle Label)
Principal Display Panel (100 mg Tablet Bottle Label)
Principal Display Panel (150 mg Tablet Bottle Label)
Principal Display Panel (200 mg Tablet Bottle Label)
Principal Display Panel (250 mg Tablet Bottle Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.